Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Bianca Goemans

Pediatric oncologist / ass. group leader
-
Phone +31 88 972 95 20
  • Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia

    • jun. 2024
    • Romy E, van Weelderen, et al
    • Blood advances
  • Oncogenic and immunological targets for matched therapy of pediatric blood cancer patients

    • jan. 2024
    • Judith M, Boer, et al
    • HemaSphere
  • Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood KMT2A-Rearranged Acute Myeloid Leukemia

    • jun. 2023
    • Romy E, van Weelderen, et al
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Outcome of children with relapsed acute myeloid leukemia improved over time in the Netherlands between 1998 and 2018

    • mrt. 2023
    • Jasper J., van de Pol, et al
    • EJC Paediatric Oncology
  • Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia

    • jan. 2023
    • Eline J M, Bertrums, et al
    • Haematologica
View all publications